Treatment class, disease duration, obesity, alcohol consumption, smoking habit, or gender showed no effect on the serum levels of TNF-α, IL-12/23, IL-17A, or IL-17F at the onset or after 12 weeks of biological therapy. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.